BANCOVID, the first D614G variant mRNA-based vaccine candidate against SARS-CoV-2 elicits neutralizing antibody and balanced cellular immune response
J. C. Baray, M. M. R. Khan, A. Mahmud, M. J. Islam, S. Myti, M. R. Ali, M. E. H. Sarker, S. Kumar, M. M. H. Chowdhury, R. Roy, F. Islam, U. Barman, H. Khan, S. Chakraborty, M. M. Hossain, , K. Nag
This paper develops and characterizes an mRNA-LNP vaccine candidate targeting the D614G variant of SARS-CoV-2, showing neutralizing antibody and balanced cellular immune responses in preclinical trials.
bioRxiv · Sep 29, 2020 · PreprintImmunology